ACHIEVE LIFE SCIENCES, INC. Insider Trading for January 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACHIEVE LIFE SCIENCES, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ACHIEVE LIFE SCIENCES, INC. for January 2017.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 4,687 | 0 | 9,375 | |
Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 3,125 | 0 | 3,125 | |
Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 2,500 | 0 | 0 | |
Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Payment of Exercise | F | 0.63 | 3,369 | 2,122 | 84,359 | 87.7 K to 84.4 K (-3.84 %) |
Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Buy | M | 0.00 | 10,312 | 0 | 87,728 | 77.4 K to 87.7 K (+13.32 %) |
Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | Bencich John | CFO | Option Exercise | M | 0.00 | 3,125 | 0 | 6,250 | |
Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | Bencich John | CFO | Payment of Exercise | F | 0.63 | 1,021 | 643 | 11,588 | 12.6 K to 11.6 K (-8.10 %) |
Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | Bencich John | CFO | Buy | M | 0.00 | 3,125 | 0 | 12,609 | 9.5 K to 12.6 K (+32.95 %) |
Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 4,687 | 0 | 9,375 | |
Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 3,125 | 0 | 3,125 | |
Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 2,500 | 0 | 0 | |
Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 9,375 | 0 | 18,750 | |
Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 6,250 | 0 | 6,250 | |
Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 4,687 | 0 | 0 | |
Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Buy | M | 0.00 | 10,312 | 0 | 84,055 | 73.7 K to 84.1 K (+13.98 %) |
Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Payment of Exercise | F | 0.63 | 9,690 | 6,105 | 140,050 | 149.7 K to 140.1 K (-6.47 %) |
Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Buy | M | 0.00 | 20,312 | 0 | 149,740 | 129.4 K to 149.7 K (+15.69 %) |